HomeRGLS • NASDAQ
add
Regulus Therapeutics Inc
$1.71
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$1.71
Sarado: Okt 7, 4:04:55 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.58
Sakop ng araw
$1.58 - $1.72
Sakop ng taon
$1.08 - $3.79
Market cap
111.95M USD
Average na Volume
340.05K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 3.95M | 68.92% |
Net na kita | -11.04M | -57.36% |
Net profit margin | — | — |
Kita sa bawat share | -0.17 | 54.05% |
EBITDA | -12.17M | -67.46% |
Aktuwal na % ng binabayarang buwis | -0.01% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 94.46M | 153.50% |
Kabuuang asset | 104.12M | 138.55% |
Kabuuang sagutin | 5.94M | -38.47% |
Kabuuang equity | 98.18M | — |
Natitirang share | 65.47M | — |
Presyo para makapag-book | 1.05 | — |
Return on assets | -28.09% | — |
Return on capital | -29.28% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -11.04M | -57.36% |
Cash mula sa mga operasyon | -11.64M | -86.13% |
Cash mula sa pag-invest | -83.00K | — |
Cash mula sa financing | -744.00K | -105.63% |
Net change in cash | -12.46M | -279.21% |
Malayang cash flow | -7.71M | -47.96% |
Tungkol
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Itinatag
Set 2007
Website
Mga Empleyado
31
